Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aker BioMarine ASAFRA:1PG -4.51%58 Forward PE Ratio is 420.91 as of Sep. 14, 2026. GuruFocus rates FRA:1PG with a GF Score™ of 58/100 and a GF Value™ of €6.79 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 760 Consumer Packaged Goods companies, Aker BioMarine ASA ranks worse than 92.89% on this metric.
Aker BioMarine ASA (FRA:1PG) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Aker BioMarine ASA Forward PE Ratio Related Terms
Aker BioMarine ASA Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Aker BioMarine ASA's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aker BioMarine ASA Forward PE Ratio Chart
Aker BioMarine ASA Annual Data
Trend
2021-12
2022-12
2023-12
2024-12
2025-12
Forward PE Ratio
188.68
12.84
12.71
37.72
36.68
Aker BioMarine ASA Semi-Annual Data
2021-06
2021-12
2022-06
2022-12
2023-06
2023-12
2024-06
2024-12
2025-06
2025-12
2026-06
Forward PE Ratio
34.60
188.68
119.05
12.84
27.62
12.71
23.98
37.72
70.00
36.68
73.42
FRA:1PG vs KHC, GIS, MKC: Forward PE Ratio Comparison
For the Packaged Foods subindustry, Aker BioMarine ASA's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aker BioMarine ASA Forward PE Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Aker BioMarine ASA's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Aker BioMarine ASA's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Aker BioMarine ASA (FRA:1PG) has a Forward PE Ratio of 420.91 as of Sep. 14, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Aker BioMarine ASA and its competitors. According to the industry distribution chart, Aker BioMarine ASA ranks #706 out of 760 companies in the Consumer Packaged Goods industry, placing it in the top 92.9%.
Is Aker BioMarine ASA's Forward PE Ratio too high?
Aker BioMarine ASA's current Forward PE Ratio is 420.91. The Consumer Packaged Goods industry median Forward PE Ratio is 12.65. Aker BioMarine ASA's value of 420.91 is 3227.4% above this industry median. Based on the distribution chart, Aker BioMarine ASA ranks #706 out of 760 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Aker BioMarine ASA has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aker BioMarine ASA's Forward PE Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Aker BioMarine ASA ranks #706 out of 760 companies for Forward PE Ratio. This places Aker BioMarine ASA in the lower half of its industry. The industry median Forward PE Ratio is 12.65. Aker BioMarine ASA's value of 420.91 is 3227.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Consumer Packaged Goods company?
The median Forward PE Ratio among Consumer Packaged Goods companies is 12.65, based on 760 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aker BioMarine ASA's current Forward PE Ratio of 420.91 is 3227.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Aker BioMarine ASA and its competitors. For the Consumer Packaged Goods industry, the median Forward PE Ratio is 12.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aker BioMarine ASA's current Forward PE Ratio is 420.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aker BioMarine ASA stock overvalued right now?
Based on GuruFocus' analysis, Aker BioMarine ASA (FRA:1PG) is currently considered Significantly Overvalued. The stock's GF Value™ is €6.79, compared to a current price of €11.86 — trading 74.7% above its estimated fair value. The current Forward PE Ratio is 420.91 and 3227.4% above the Consumer Packaged Goods industry median of 12.65. Aker BioMarine ASA's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Aker BioMarine ASA (FRA:1PG), the current Forward PE Ratio is 420.91 as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aker BioMarine ASA (FRA:1PG) Overvalued in 2026?
Based on GuruFocus' analysis, Aker BioMarine ASA stock appears to be overvalued.
The current stock price of €11.86 is trading 74.7% above its estimated GF Value™ of €6.79.
GuruFocus considers Aker BioMarine ASA to be Significantly Overvalued.
Key valuation signals for FRA:1PG:
Forward PE Ratio: 420.91
GF Value™: €6.79 vs. price of €11.86 (74.7% above fair value)
Industry Position: 3227.4% above the Consumer Packaged Goods median (#706 of 760)
No single metric tells the full story. See the FRA:1PG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include Human Health Ingredients, Consumer Health Products, and Emerging Businesses. The company generates the majority of its revenue from the Human Health Ingredients segment, which includes Superba, Lysoveta, PL+ Algae, and the company's Houston manufacturing plant. The segment sells B2B krill oil supplements to nutritional brands for humans around the world.
58GF Score
Get the complete analysis for FRA:1PG
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1PG has been successfully added to your 
